Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?

J Nijs, M Meeus, J Versijpt, M Moens, I Bos… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Central sensitization is a form of maladaptive neuroplasticity underlying many
chronic pain disorders, including neuropathic pain, fibromyalgia, whiplash, headache …

The role of the brain-derived neurotrophic factor in chronic pain: links to central sensitization and neuroinflammation

HY Xiong, J Hendrix, S Schabrun, A Wyns… - Biomolecules, 2024 - mdpi.com
Chronic pain is sustained, in part, through the intricate process of central sensitization (CS),
marked by maladaptive neuroplasticity and neuronal hyperexcitability within central pain …

Nerve growth factor & TrkA as novel therapeutic targets in cancer

IE Demir, E Tieftrunk, S Schorn, H Friess… - Biochimica et Biophysica …, 2016 - Elsevier
In the past 20 years, nerve growth factor (NGF) and its receptors TrkA & p75NTR were
recognized to be overexpressed in the overwhelming majority of human solid cancers …

Peripheral mechanism of cancer-induced bone pain

Y Yang, W Yang, R Zhang, Y Wang - Neuroscience Bulletin, 2024 - Springer
Cancer-induced bone pain (CIBP) is a type of ongoing or breakthrough pain caused by a
primary bone tumor or bone metastasis. CIBP constitutes a specific pain state with distinct …

Oral squamous cell carcinoma–released brain-derived neurotrophic factor contributes to oral cancer pain by peripheral tropomyosin receptor kinase B activation

M Grayson, D Arris, P Wu, J Merlo, T Ibrahim… - Pain, 2022 - journals.lww.com
1. Background Quality of life of patients with head and neck cancer (HNC) is notoriously
poor because of the greater prevalence of pain compared with other cancer types. 15, 42 …

Use of animal models in understanding cancer-induced bone pain

LM Slosky, TM Largent-Milnes… - Cancer growth and …, 2015 - journals.sagepub.com
Many common cancers have a propensity to metastasize to bone. Although malignancies
often go undetected in their native tissues, bone metastases produce excruciating pain that …

BDNF signaling contributes to oral cancer pain in a preclinical orthotopic rodent model

L Chodroff, M Bendele, V Valenzuela… - Molecular …, 2016 - journals.sagepub.com
The majority of patients with oral cancer report intense pain that is only partially managed by
current analgesics. Thus, there is a strong need to study mechanisms as well as develop …

[HTML][HTML] A pathogenic role for brain-derived neurotrophic factor (BDNF) in fibrous dysplasia of bone

B Palmisano, G Farinacci, F Campolo, C Tavanti… - Bone, 2024 - Elsevier
Brain derived neurotrophic factor (BDNF) is a neurotrophin, expressed in the central nervous
system and in peripheral tissues, that is regulated by the Gsα/cAMP pathway. In bone, it …

Inhibiting BDNF/TrkB. T1 receptor improves resiniferatoxin-induced postherpetic neuralgia through decreasing ASIC3 signaling in dorsal root ganglia

X Wei, L Wang, J Hua, X Jin, F Ji, K Peng… - Journal of …, 2021 - Springer
Background Postherpetic neuralgia (PHN) is a devastating complication after varicella-
zoster virus infection. Brain-derived neurotrophic factor (BDNF) has been shown to …

The impact of bone cancer on the peripheral encoding of mechanical pressure stimuli

MW Kucharczyk, KI Chisholm, F Denk, AH Dickenson… - Pain, 2020 - journals.lww.com
Skeletal metastases are frequently accompanied by chronic pain that is mechanoceptive in
nature. Mechanistically, cancer-induced bone pain (CIBP) is mediated by peripheral sensory …